Crinetics Pharmaceuticals (CRNX) Revenue (QoQ) (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) Revenue (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.73 Bn | 7.44 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.22% |
| Dec 31, 2025 | 4,208.39% |
| Sep 30, 2025 | -86.13% |
| Jun 30, 2025 | 185.60% |
| Jun 30, 2024 | -37.66% |
| Sep 30, 2023 | -64.98% |
| Jun 30, 2023 | -63.12% |
| Mar 31, 2023 | 277.86% |
| Dec 31, 2022 | 54.80% |
| Sep 30, 2022 | 4.33% |
| Jun 30, 2022 | -85.98% |
| Mar 31, 2022 | 190.45% |
| Mar 31, 2020 | -77.88% |
| Dec 31, 2019 | -36.44% |
| Mar 31, 2019 | -53.01% |
| Dec 31, 2018 | 42.52% |
| Sep 30, 2018 | -16.59% |
| Jun 30, 2018 | 48.64% |
| Mar 31, 2018 | -16.29% |
| Dec 31, 2017 | -17.50% |